Annovis Bio, Inc. ANVS

Set alert

Price alert · ANVS

All alert types
1.08 USD -0.05 -4.42%

At close

1.05 -0.03 -2.64%

Pre-market · Nov 3, 7:47 AM ET

Bid
1.08 × 2,500
Ask
1.09 × 1,500
1.05 Day range 1.40
0.93 52-week range 5.50
YTD
-68.79%
1 year
-48.57%
Open
1.17
Prev close
1.13
Mkt cap
46.09M
Vol
3.01M
Avg vol
942.79K
EPS
-1.75
P/E
0.00
Div yield
0.00%
More statistics
Low
1.05
High
1.40
Forward P/E
-2.77
Beta
0.00
Short ratio
6.21
Inst. own
8.83%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
7.29
200-d avg
8.47
1y target
34.80

5D chart

Chart tools
Interval

Signals (104)
NameTimeAgo
SMA: BullishNov 2, 1:45 PM18 hours ago
MACD: Buy SignalNov 2, 1:45 PM18 hours ago
RSI: OversoldNov 2, 1:25 PM18 hours ago
SMA: BearishNov 2, 12:40 PM19 hours ago
SMA: BullishNov 2, 12:35 PM19 hours ago
SMA: BearishNov 2, 10:55 AM21 hours ago
MACD: Sell SignalNov 2, 10:40 AM21 hours ago
SMA: BearishNov 2, 10:30 AM21 hours ago
MACD: Buy SignalNov 2, 9:35 AM22 hours ago
RSI: OverboughtNov 2, 9:35 AM22 hours ago
SMA: BearishOct 30, 3:45 PM3 days ago
SMA: BullishOct 30, 3:35 PM3 days ago
SMA: BearishOct 30, 3:30 PM3 days ago
MACD: Sell SignalOct 30, 3:30 PM3 days ago
RSI: OverboughtOct 30, 3:10 PM3 days ago
RSI: OverboughtOct 30, 2:25 PM3 days ago
MACD: Buy SignalOct 30, 2:15 PM3 days ago
MACD: Sell SignalOct 30, 2:05 PM3 days ago
MACD: Buy SignalOct 30, 2:00 PM3 days ago
RSI: OverboughtOct 30, 2:00 PM3 days ago

Newest 20 of 104.

Analyst view

Consensus: buy

Buy
Price target (mean) 34.80 +3122.2% upside
Target (low)
21.00
Target (mean)
34.80
Target (high)
72.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6
  • 3 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ANVS analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.20-0.20 – -0.200.000.0%00.0%1
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-1.71-1.71 – -1.710.000.0%00.0%1
Next year-0.87-0.87 – -0.87-1.71+49.1%00.0%1

Upgrades and downgrades

The latest rating changes

ANVS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024D. Boral CapitalMaintainedBuyBuy
Nov 11, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 25, 2024Maxim GroupUpgradeHoldBuy
Aug 15, 2024EF HuttonMaintainedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 13, 2024EF HuttonInitiated—Buy
Jul 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 11, 2024HC Wainwright & Co.MaintainedBuyBuy
Jul 2, 2024Rodman & RenshawReiteratedBuyBuy
Jun 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 4, 2024Rodman & RenshawInitiated—Buy
May 13, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 30, 2024Canaccord GenuityMaintainedBuyBuy
Apr 30, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 2, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 28, 2024Brookline CapitalDowngradeBuyHold
Dec 29, 2023Canaccord GenuityInitiated—Buy
Nov 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 10, 2023Brookline CapitalInitiated—Buy
Aug 15, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 9, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 21, 2023HC Wainwright & Co.Reiterated—Buy
Feb 8, 2023HC Wainwright & Co.Reiterated—Buy
Sep 8, 2022HC Wainwright & Co.Initiated—Buy
May 2, 2022Ladenburg ThalmannInitiated—Buy